Jiehui Deng

14PUBLICATIONS
175CO-AUTHORS
Molecular targetsRadiation therapyDeep learningCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 01, 2026
Autophagy Inhibition Reprograms the Tumor Microenvironment of Pancreatic Cancer to Promote Macrophage Phagocytosis of Tumor Cells.

|Apr 21, 2026
Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-κB-Mediated Inflammatory Response in Triple-Negative Breast Cancer.

|Nov 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.

Benjamin T Cooper, Wade T Iams, David B Page

|Aug 29, 2025
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.

Leanne G Ahronian, Soumyadip Sahu, Minjie Zhang

|Feb 20, 2025
Characterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data.

Jimin Tan, Hortense Le, Jiehui Deng

|Feb 10, 2024
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

David R Wise, Russell K Pachynski, Samuel R Denmeade

Pageof 3

Frequent Collaborators

8 joint publications

Kwok-Kin Wong

5 joint publications

Ting Chen

4 joint publications

Aristotelis Tsirigos

3 joint publications

Michela Ranieri